Epimacular MembraneNCT04158791
Outcomes Based on the Pre-operative Integrity of IS/OS Junction in Idiopathic Epimacular Membrane Surgery
An observational study of Epimacular Membrane, run by Fondazione IRCCS Policlinico San Matteo di Pavia at 1 site in Italy.
Trial summary
The aim of this study is to evaluate whether the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction may influence the post-operative visual acuity, the macular morphology (assessed by Spectral Domain-Optical Coherence Tomography (SD-OCT)) and function (evaluated by… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Epimacular Membrane
- What is being tested?
- pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peeling
- Type of treatment
- Surgery or procedure
- How many people
- 18 participants
- Where
- 1 siteItaly
- Study dates
- 25 Mar 2018to 9 Jul 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients with idiopathic EMM, undergoing pars plana vitrectomy with ILM peeling, at the Ophtalmology Clinic of IRCCS Policlinico San Matteo
Who may be able to join
- patients with idiopathic epimacular membrane
Who cannot join
- presence of dense lens opacities, ocular hypertension or glaucoma, diabetic retinopathy, drusen and age-related macular disease, other general diseases such as systemic hypertension, diabetes, connective tissue or neurological diseases.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Surgery for Idiopathic Epimacular Membrane: Morpho-functional Outcomes Based on the Pre-operative Macular Integrity of Photoreceptoral Junction. A Prospective Pilot Study.
The aim of this study is to evaluate whether the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction may influence the post-operative visual acuity, the macular morphology (assessed by Spectral Domain-Optical Coherence Tomography (SD-OCT)) and function (evaluated by Multifocal Electroretinogram -mfERG) in patients with idiopathic epimacular membrane (EMM) followed-up for 6-month.
In this observational prospective study, EMM patients are enrolled. They are divided into 2 groups in relationship to the pre-operative integrity of the SD-OCT IS/OS junction: the group with an intact IS/OS junction (EMM-I Group) and the group with a disrupted IS/OS junction (EMM-D Group). For each enrolled patient, visual acuity (VA), mfERG and SD-OCT were assessed at baseline (pre-operative) and after 1, 3 and 6 months of follow-up after surgical treatment for EMM (pars plana vitrectomy with EMM removal and internal limiting membrane peeling).
Read the detailed description
In this observational study, patients with idiopathic EMM, undergoing pars plana vitrectomy with Inner Limiting Membrane (ILM) peeling, at the Ophtalmology Clinic of IRCCS Policlinico San Matteo, are enrolled.
The clinical diagnosis of EMM is based on indirect binocular ophthalmoscopy with a + 90 D no-contact lens (Volk Optical Inc., Ohio, USA) and on the SD-OCT examination (see below) which revealed an increase in macular volume associated with optically hyperreflective epiretinal echoes due to the presence of a membrane.
Since several pathologies may induce changes of the macula bioelectrical responses, and their presence may represent potential confounding factors, patients enrolled in the present study were selected from a large EMM cohort of patients after exclusion of presence of dense lens opacities, ocular hypertension or glaucoma, diabetic retinopathy, drusen and age-related macular disease, other general diseases such as systemic hypertension, diabetes, connective tissue or neurological diseases.
Based on that reported by Falkner-Radler et al. , our patient are divided into 2 groups in relationship to the integrity of IS/OS junction: a group in which an intact IS/OS junction was identified by SD-OCT examination (EMM-I Group) and a group in which a disrupted IS/OS junction was observed by SD-OCT examination, EMM-D Group.
Evaluation of photoreceptor status is performed on the central part of the 1.5 mm of two perpendicular scans centered on the fovea. The intact IS/OS junction is identified as a continuous hyperreflective line ; the disrupted IS/OS junction is identified as interruptions of the normal hyperreflective line. Classification was assessed by the agreement of two different grader. In case of disagreement a third assessment was obtained by another expert grader.
VA, mfERG and SD-OCT were assessed in each enrolled patient at baseline (pre-operative) and after 1, 3 and 6 month of follow-up after surgical treatment for EMM in each enrolled patient.
Surgical treatment
All the patients undergo a 25-gauge pars plana vitrectomy with a solution of 0.15% trypan blue, 0.025% brilliant blue G, 4% polyethylene glycol (MembraneBlue Dual) assisted Epiretinal Membrane/Inner Limiting Membrane (ERM/ILM) removal performed by a single surgeon (GV); no air-fluid exchange is performed during surgery. In phakic eyes, phacoemulsification with intraocular lens implantation was performed at the time of vitrectomy.
Visual acuity evaluation
Best-corrected VA is assessed by the modified ETDRS Charts (Lighthouse, Low vision products, Long Island City, N.Y. USA) and expressed in LogMAR values obtained at the distance of 4, 2, 1 and 0.5 meters.
MfERG recordings
The Espion D310 Profile Multifocal System (Diagnosis UK LTD, Histon, Cambridge, UK) is used to record the mfERG.
In all eyes, mfERGs are binocularly recorded under photopic conditions in normal room illumination. Pupils are maximally pharmacologically dilated with 1% tropicamide to a diameter of 7-8 mm. Binocular mfERG recording is preferred for helping subjects to have a stable target fixation. At every mfERG examination, each patient positively reported that he/she could clearly perceive the cross fixation target. The eye's position is continuously monitored by a fixation camera to track patient gaze.
The cornea is anesthetized with 0.4% oxybuprocaine. MfERGs are recorded bipolarly between an active electrode (Dawson-Trick-Litzkow -DTL- thread electrodes) and a reference Ag/AgCl electrode placed on the temple. A small Ag/AgCl skin ground electrode s placed at the center of the forehead. Interelectrode resistance is less than 5 KOhms.
The multifocal achromatic stimulus, consisting of 61 scaled hexagons, is displayed on a high-resolution liquid crystal displays (LCD), black-and-white 32" (diagonal) monitor (size 70 cm width and 39.5 cm height) with a frame rate of 75 Hz (base period for stimulus presentation is 13.3 ms). The hexagon-shaped stimuli are arranged along several concentric rings and are randomly alternated between black (1 cd/m2) and white (400 cd/m2), with the on-off string of each hexagon determined according to a 14-bit M-sequence. This resulted in a contrast of 99%. The luminance of the monitor screen is 200 cd/m2 and a central fixation red cross is used as target in the center of the stimulation field. The eccentricity of the outermost ring of the 61-hexagon array is about 30° (radius from the fixation point to edge of display).
The m-sequence had 213-1 elements and total recording time is approximately 5 min. Total recording time is divided into 9 segments, with a duration of 30 seconds each. Between segments, the subject is allowed to rest for a few seconds.
The signal is amplified (gain 100.000) and filtered (band pass 10-100 Hz) by LPC2000 Flash Utility software V2.2.1. After automatic rejection of artefacts (and blinks) and application of line current (50 or 60 Hz) interference filter (or Runtime Mains Rejection), and automatic rejection of the bioelectrical responses with noise greater than 1 μV root mean square (RMS), the system software (V6.58.2) provided the 1st order kernel response, that was normalized considering the ratio between the bioelectrical responses and the relative retinal area from which the signals were collected. In the 1st order kernel response, different peaks (called with the letter indicating the negative, N and positive, P polarity and the sequential number of appearance) are identified in a time after the 0 ms corresponding to the presentation of the visual stimuli.
In the analysis of normalized mfERG responses, the investigator considered the peak-to-peak amplitude between N1 and P1 peaks, called response amplitude density (RAD) measured in nanoVolt/degree2 (ɳV/deg2).
MfERG ring analysis is selected to differentiate changes of the bioelectrical responses of the foveal region with respect to the more eccentric macular areas. The investigators analyze the averaged response obtained from two concentric annular retinal regions (rings, R) centered on the fovea. Therefore, the investigators analyze the N1-P1 RADs derived from 0 to 5° (R1) and from 5 to 10° (R2).
SD-OCT assessment
All patients undergo structural SD-OCT scan using Heidelberg Spectralis (version 1.10.4.0, Heidelberg Engineering, Heidelberg Germany) after pupil dilation. The SD-OCT imaging protocol consist of at least 20°x15° volume scans of the macula area with 19 B-scans.
A qualitative analysis is performed in order to evaluate the integrity of the inner segment and outer segment photoreceptoral junction . Quantitative analysis of central retinal thickness (CRT), including the overall, the inner (I-CRT) and outer (O-CRT) CRT, and macular volume (MV) are automatically obtained from the macular map centered to the fovea, through an inbuilt software of Heidelberg Spectralis (version 1.10.2.0).
The research follows the tenets of the Declaration of Helsinki. Each patient signed an informed consent. The study was performed according to our routine clinical practice, thus IRB approval was not required.
Statistical Analysis
The Anderson-Darling and Kolmogorov-Smirnovtests are applied to verify that data were normally distributed. Only one eye is chosen for each patient.
Pearson's correlation is used to assess the relationship between the differences (logarithmic values at 1, 3 and 6 months minus logarithmic values at baseline) in VA and mfERG and SD-OCT data. All statistical analyses is performed using SPSS V.26 (Statistical Package for Social Science IBM), and a p-value less than 0.05 is considered as statistically significant.
- Conditions
- Epimacular Membrane
- Being tested
- pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peeling
- Keywords
- Ophthalmology, Epimacular membrane, ILM peeling, mfERG, OCT
- Medical subject headings
- Epiretinal Membrane
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peelingProcedure or surgery
25-gauge pars plana vitrectomy with a solution of 0.15% trypan blue, 0.025% brilliant blue G, 4% polyethylene glycol (MembraneBlue Dual) assisted ERM/ILM removal performed by a single surgeon (GV); no air-fluid exchange was performed during surgery. In phakic eyes, phacoemulsification with intraocular lens implantation was performed at the time of vitrectomy.
| Study group | Role | What they receive |
|---|---|---|
| EMM-I | Group with an intact IS/OS junction Receives: Procedure: pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peeling | |
| EMM-D | Group with a disrupted IS/OS junction Receives: Procedure: pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peeling |
What is being measured
The primary outcome is the main question the study is designed to answer.
Imortance of the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction in the change of the post-operative visual acuity after 1, 3 and 6 months of follow-up after surgical treatment for EMM
Visual acuity (VA)was assessed at baseline (pre-operative) and after 1, 3 and 6 months of follow-up after surgical treatment for EMM (pars plana vitrectomy with EMM removal and internal limiting membrane peeling
Measured: 6 months
Importance of the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction in the change of the post-operative macular morphology after 1, 3 and 6 months of follow-up after surgical treatment for EMM
SD-OCT (assessing macular morphology) was assessed at baseline (pre-operative) and after 1, 3 and 6 months of follow-up after surgical treatment for EMM (pars plana vitrectomy with EMM removal and internal limiting membrane peeling
Measured: 6 months
Importance of the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction in the change of the post-operative macular function after 1, 3 and 6 months of follow-up after surgical treatment for EMM
mfERG (assessing macular function) was assessed at baseline (pre-operative) and after 1, 3 and 6 months of follow-up after surgical treatment for EMM (pars plana vitrectomy with EMM removal and internal limiting membrane peeling
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Nov 2019
- Study start25 Mar 2018
- Primary completion15 Feb 2019
- Study completion9 Jul 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Epimacular MembraneStudies of the same condition, open and under way.
- More trials run by Fondazione IRCCS Policlinico San Matteo di PaviaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 18 participants (actual)
Sponsor and investigators
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Carlo Bruttini, Fondazione IRCCS Policlinico San Matteo di Pavia
- Investigators
- Luciano Quaranta, Professor, Study director, IRCCS Policlinico San Matteo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04158791
- Sponsor's protocol ID
- SIEM28O219
- Status last verified
- Nov 2019
- First submitted
- 31 Oct 2019
- Last updated
- 13 Nov 2019
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 13 Nov 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Surgery for Idiopathic Epimacular Membrane: Morpho-functional Outcomes Based on the Pre-operative Macular Integrity of Photoreceptoral Junction. A Prospective Pilot Study.
- ClinicalTrials.gov ID
- NCT04158791
- Acronym / sponsor ID
- SIEM28O219
- Conditions
- Epimacular Membrane
- Keywords
- Ophthalmology, Epimacular membrane, ILM peeling, mfERG, OCT
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 18 participants (actual)
- Lead sponsor
- Fondazione IRCCS Policlinico San Matteo di PaviaUniversity, hospital or other
- Study start
- 25 Mar 2018 (actual)
- Primary completion
- 15 Feb 2019 (actual)
- Study completion
- 9 Jul 2019 (actual)
- First posted
- 12 Nov 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to evaluate whether the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction may influence the post-operative visual acuity, the macular morphology (assessed by Spectral Domain-Optical Coherence Tomography (SD-OCT)) and function (evaluated by Multifocal Electroretinogram -mfERG) in patients with idiopathic epimacular membrane (EMM) followed-up for 6-month.
In this observational prospective study, EMM patients are enrolled. They are divided into 2 groups in relationship to the pre-operative integrity of the SD-OCT IS/OS junction: the group with an intact IS/OS junction (EMM-I Group) and the group with a disrupted IS/OS junction (EMM-D Group). For each enrolled patient, visual acuity (VA), mfERG and SD-OCT were assessed at baseline (pre-operative) and after 1, 3 and 6 months of follow-up after surgical treatment for EMM (pars plana vitrectomy with EMM removal and internal limiting membrane peeling).
Detailed description
In this observational study, patients with idiopathic EMM, undergoing pars plana vitrectomy with Inner Limiting Membrane (ILM) peeling, at the Ophtalmology Clinic of IRCCS Policlinico San Matteo, are enrolled.
The clinical diagnosis of EMM is based on indirect binocular ophthalmoscopy with a + 90 D no-contact lens (Volk Optical Inc., Ohio, USA) and on the SD-OCT examination (see below) which revealed an increase in macular volume associated with optically hyperreflective epiretinal echoes due to the presence of a membrane.
Since several pathologies may induce changes of the macula bioelectrical responses, and their presence may represent potential confounding factors, patients enrolled in the present study were selected from a large EMM cohort of patients after exclusion of presence of dense lens opacities, ocular hypertension or glaucoma, diabetic retinopathy, drusen and age-related macular disease, other general diseases such as systemic hypertension, diabetes, connective tissue or neurological diseases.
Based on that reported by Falkner-Radler et al. , our patient are divided into 2 groups in relationship to the integrity of IS/OS junction: a group in which an intact IS/OS junction was identified by SD-OCT examination (EMM-I Group) and a group in which a disrupted IS/OS junction was observed by SD-OCT examination, EMM-D Group.
Evaluation of photoreceptor status is performed on the central part of the 1.5 mm of two perpendicular scans centered on the fovea. The intact IS/OS junction is identified as a continuous hyperreflective line ; the disrupted IS/OS junction is identified as interruptions of the normal hyperreflective line. Classification was assessed by the agreement of two different grader. In case of disagreement a third assessment was obtained by another expert grader.
VA, mfERG and SD-OCT were assessed in each enrolled patient at baseline (pre-operative) and after 1, 3 and 6 month of follow-up after surgical treatment for EMM in each enrolled patient.
Surgical treatment
All the patients undergo a 25-gauge pars plana vitrectomy with a solution of 0.15% trypan blue, 0.025% brilliant blue G, 4% polyethylene glycol (MembraneBlue Dual) assisted Epiretinal Membrane/Inner Limiting Membrane (ERM/ILM) removal performed by a single surgeon (GV); no air-fluid exchange is performed during surgery. In phakic eyes, phacoemulsification with intraocular lens implantation was performed at the time of vitrectomy.
Visual acuity evaluation
Best-corrected VA is assessed by the modified ETDRS Charts (Lighthouse, Low vision products, Long Island City, N.Y. USA) and expressed in LogMAR values obtained at the distance of 4, 2, 1 and 0.5 meters.
MfERG recordings
The Espion D310 Profile Multifocal System (Diagnosis UK LTD, Histon, Cambridge, UK) is used to record the mfERG.
In all eyes, mfERGs are binocularly recorded under photopic conditions in normal room illumination. Pupils are maximally pharmacologically dilated with 1% tropicamide to a diameter of 7-8 mm. Binocular mfERG recording is preferred for helping subjects to have a stable target fixation. At every mfERG examination, each patient positively reported that he/she could clearly perceive the cross fixation target. The eye's position is continuously monitored by a fixation camera to track patient gaze.
The cornea is anesthetized with 0.4% oxybuprocaine. MfERGs are recorded bipolarly between an active electrode (Dawson-Trick-Litzkow -DTL- thread electrodes) and a reference Ag/AgCl electrode placed on the temple. A small Ag/AgCl skin ground electrode s placed at the center of the forehead. Interelectrode resistance is less than 5 KOhms.
The multifocal achromatic stimulus, consisting of 61 scaled hexagons, is displayed on a high-resolution liquid crystal displays (LCD), black-and-white 32" (diagonal) monitor (size 70 cm width and 39.5 cm height) with a frame rate of 75 Hz (base period for stimulus presentation is 13.3 ms). The hexagon-shaped stimuli are arranged along several concentric rings and are randomly alternated between black (1 cd/m2) and white (400 cd/m2), with the on-off string of each hexagon determined according to a 14-bit M-sequence. This resulted in a contrast of 99%. The luminance of the monitor screen is 200 cd/m2 and a central fixation red cross is used as target in the center of the stimulation field. The eccentricity of the outermost ring of the 61-hexagon array is about 30° (radius from the fixation point to edge of display).
The m-sequence had 213-1 elements and total recording time is approximately 5 min. Total recording time is divided into 9 segments, with a duration of 30 seconds each. Between segments, the subject is allowed to rest for a few seconds.
The signal is amplified (gain 100.000) and filtered (band pass 10-100 Hz) by LPC2000 Flash Utility software V2.2.1. After automatic rejection of artefacts (and blinks) and application of line current (50 or 60 Hz) interference filter (or Runtime Mains Rejection), and automatic rejection of the bioelectrical responses with noise greater than 1 μV root mean square (RMS), the system software (V6.58.2) provided the 1st order kernel response, that was normalized considering the ratio between the bioelectrical responses and the relative retinal area from which the signals were collected. In the 1st order kernel response, different peaks (called with the letter indicating the negative, N and positive, P polarity and the sequential number of appearance) are identified in a time after the 0 ms corresponding to the presentation of the visual stimuli.
In the analysis of normalized mfERG responses, the investigator considered the peak-to-peak amplitude between N1 and P1 peaks, called response amplitude density (RAD) measured in nanoVolt/degree2 (ɳV/deg2).
MfERG ring analysis is selected to differentiate changes of the bioelectrical responses of the foveal region with respect to the more eccentric macular areas. The investigators analyze the averaged response obtained from two concentric annular retinal regions (rings, R) centered on the fovea. Therefore, the investigators analyze the N1-P1 RADs derived from 0 to 5° (R1) and from 5 to 10° (R2).
SD-OCT assessment
All patients undergo structural SD-OCT scan using Heidelberg Spectralis (version 1.10.4.0, Heidelberg Engineering, Heidelberg Germany) after pupil dilation. The SD-OCT imaging protocol consist of at least 20°x15° volume scans of the macula area with 19 B-scans.
A qualitative analysis is performed in order to evaluate the integrity of the inner segment and outer segment photoreceptoral junction . Quantitative analysis of central retinal thickness (CRT), including the overall, the inner (I-CRT) and outer (O-CRT) CRT, and macular volume (MV) are automatically obtained from the macular map centered to the fovea, through an inbuilt software of Heidelberg Spectralis (version 1.10.2.0).
The research follows the tenets of the Declaration of Helsinki. Each patient signed an informed consent. The study was performed according to our routine clinical practice, thus IRB approval was not required.
Statistical Analysis
The Anderson-Darling and Kolmogorov-Smirnovtests are applied to verify that data were normally distributed. Only one eye is chosen for each patient.
Pearson's correlation is used to assess the relationship between the differences (logarithmic values at 1, 3 and 6 months minus logarithmic values at baseline) in VA and mfERG and SD-OCT data. All statistical analyses is performed using SPSS V.26 (Statistical Package for Social Science IBM), and a p-value less than 0.05 is considered as statistically significant.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| EMM-I | – | Procedure: pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peelingGroup with an intact IS/OS junction |
| EMM-D | – | Procedure: pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peelingGroup with a disrupted IS/OS junction |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients with idiopathic EMM, undergoing pars plana vitrectomy with ILM peeling, at the Ophtalmology Clinic of IRCCS Policlinico San Matteo
Key inclusion criteria (1 listed)
- patients with idiopathic epimacular membrane
Key exclusion criteria (1 listed)
- presence of dense lens opacities, ocular hypertension or glaucoma, diabetic retinopathy, drusen and age-related macular disease, other general diseases such as systemic hypertension, diabetes, connective tissue or neurological diseases.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| pars plana vitrectomy with epimacular membrane removal and internal limiting membrane peeling25-gauge pars plana vitrectomy with a solution of 0.15% trypan blue, 0.025% brilliant blue G, 4% polyethylene glycol (MembraneBlue Dual) assisted ERM/ILM removal performed by a single surgeon (GV); no air-fluid exchange was performed during surgery. In phakic eyes, phacoemulsification with intraocular lens implantation was performed at the time of vitrectomy. | Procedure or surgery | EMM-D, EMM-I |
Primary outcome
Imortance of the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction in the change of the post-operative visual acuity after 1, 3 and 6 months of follow-up after surgical treatment for EMM
Time frame: 6 months
Visual acuity (VA)was assessed at baseline (pre-operative) and after 1, 3 and 6 months of follow-up after surgical treatment for EMM (pars plana vitrectomy with EMM removal and internal limiting membrane peeling
Importance of the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction in the change of the post-operative macular morphology after 1, 3 and 6 months of follow-up after surgical treatment for EMM
Time frame: 6 months
SD-OCT (assessing macular morphology) was assessed at baseline (pre-operative) and after 1, 3 and 6 months of follow-up after surgical treatment for EMM (pars plana vitrectomy with EMM removal and internal limiting membrane peeling
Importance of the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction in the change of the post-operative macular function after 1, 3 and 6 months of follow-up after surgical treatment for EMM
Time frame: 6 months
mfERG (assessing macular function) was assessed at baseline (pre-operative) and after 1, 3 and 6 months of follow-up after surgical treatment for EMM (pars plana vitrectomy with EMM removal and internal limiting membrane peeling
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Nov 2019.
- Individual participant dataSharing planned: Undecided
Related trials for Epimacular Membrane
Recruiting
Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM
Epiretinal Membrane
RecruitingObservational study
Surgical Procedure Efficiency Evaluation stuDy
Cataract, Vitreous Hemorrhage
RecruitingObservational study
Intraoperative OCT Guidance of Intraocular Surgery II
Macular Holes, Epiretinal Membrane
Not yet recruitingObservational study
OCT Macula Biomarkers Before Silicone Oil Removal and Visual Outcome After Silicone Oil Removal
Retinal Detachment, Macular Edema
Recruiting
(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
Epiretinal Membrane, Dry Age Related Macular Degeneration
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Luciano Quaranta, Professor study director
IRCCS Policlinico San Matteo
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Epimacular Membrane, run by Fondazione IRCCS Policlinico San Matteo di Pavia at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Imortance of the pre-operative integrity or not of the inner segment (IS) and outer segment (OS) photoreceptoral junction in the change of the post-operative visual acuity after 1, 3 and 6 months of follow-up after surgical treatment for EMM (time frame: 6 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2019.